Literature DB >> 12196419

Diabetes contributes to cholesterol metabolism regardless of obesity.

Piia P Simonen1, Helena K Gylling, Tatu A Miettinen.   

Abstract

OBJECTIVE: To investigate cholesterol metabolism in obesity with and without diabetes. RESEARCH DESIGN AND METHODS: We performed cross-sectional metabolic studies in obese individuals with and without type 2 diabetes. The study population consisted of 16 obese (BMI >30 kg/m(2)) diabetic subjects with a mean age of 52 +/- 2 years (SE) and 16 nondiabetic control subjects of similar age and weight. Cholesterol absorption efficiency was measured with peroral dual isotopes and cholesterol synthesis with sterol balance.
RESULTS: Serum total cholesterol did not differ between the groups, but LDL and HDL cholesterol were significantly lower and VLDL cholesterol and serum total and VLDL triglycerides were higher in the diabetic group than in the control group. Cholesterol absorption efficiency was 29 +/- 1% in diabetic subjects vs. 42 +/- 2% in the control subjects (P < 0.01). Cholesterol synthesis was higher (17 +/- 1 vs. 14 +/- 1 mg. kg(-1). day(-1); P < 0.05) and neutral sterol and bile acid excretion and cholesterol turnover tended to be higher in the diabetic group than in the control group. Blood glucose was positively related to cholesterol synthesis in the diabetic group (r = +0.663, P < 0.01) and in the control group (r = +0.590, P < 0.05), suggesting that the higher blood glucose level, the higher the cholesterol synthesis. In addition, blood glucose was significantly positively related to fecal neutral sterol excretion in both groups.
CONCLUSIONS: Cholesterol absorption efficiency was lower and cholesterol synthesis was higher in obese subjects with diabetes than in those without diabetes, suggesting that diabetes modulates cholesterol metabolism more than obesity alone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196419     DOI: 10.2337/diacare.25.9.1511

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  33 in total

1.  Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.

Authors:  Pooja Malhotra; Costica Aloman; Aparna Ankireddy; Hani Khadra; Kohtaro Ooka; Ravinder K Gill; Seema Saksena; Pradeep K Dudeja; Waddah A Alrefai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-08-03       Impact factor: 4.052

Review 2.  MicroRNA: a connecting road between apoptosis and cholesterol metabolism.

Authors:  Yogita K Adlakha; Neeru Saini
Journal:  Tumour Biol       Date:  2016-04-22

3.  Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study.

Authors:  Helena Gylling; Maarit Hallikainen; Jussi Pihlajamäki; Piia Simonen; Johanna Kuusisto; Markku Laakso; Tatu A Miettinen
Journal:  J Lipid Res       Date:  2010-05-01       Impact factor: 5.922

Review 4.  Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer's dementia.

Authors:  Vincenzo Giordano; Gianfranco Peluso; Maurizio Iannuccelli; Paola Benatti; Raffaella Nicolai; Menotti Calvani
Journal:  Neurochem Res       Date:  2006-08-17       Impact factor: 3.996

Review 5.  Cholesterol absorption: influence of body weight and the role of plant sterols.

Authors:  Helena Gylling; Tatu A Miettinen
Journal:  Curr Atheroscler Rep       Date:  2005-11       Impact factor: 5.113

6.  Heritable IUGR and adult metabolic syndrome are reversible and associated with alterations in the metabolome following dietary supplementation of 1-carbon intermediates.

Authors:  Maxim D Seferovic; Danielle M Goodspeed; Derrick M Chu; Laura A Krannich; Pablo J Gonzalez-Rodriguez; James E Cox; Kjersti M Aagaard
Journal:  FASEB J       Date:  2015-03-10       Impact factor: 5.191

7.  Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes.

Authors:  Carlo M Rotella; Augusto Zaninelli; Cristina Le Grazie; Mary E Hanson; Gian Franco Gensini
Journal:  Lipids Health Dis       Date:  2010-07-27       Impact factor: 3.876

8.  Association between cholesterol synthesis/absorption markers and effects of cholesterol lowering by atorvastatin among patients with high risk of coronary heart disease.

Authors:  Yue Qi; Jing Liu; Changsheng Ma; Wei Wang; Xiaohui Liu; Miao Wang; Qiang Lv; Jiayi Sun; Jun Liu; Yan Li; Dong Zhao
Journal:  J Lipid Res       Date:  2013-08-20       Impact factor: 5.922

9.  Low-density-lipoprotein cholesterol concentrations and risk of incident diabetes: epidemiological and genetic insights from the Framingham Heart Study.

Authors:  Charlotte Andersson; Asya Lyass; Martin G Larson; Sander J Robins; Ramachandran S Vasan
Journal:  Diabetologia       Date:  2015-09-26       Impact factor: 10.122

10.  Progressive obesity leads to altered ovarian gene expression in the Lethal Yellow mouse: a microarray study.

Authors:  John Brannian; Kathleen Eyster; Mandi Greenway; Cody Henriksen; Kim Teslaa; Maureen Diggins
Journal:  J Ovarian Res       Date:  2009-08-03       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.